Rbbp8nl contributes to resistance to anticancer immunotherapy by creating a non-inflamed tumor microenvironment and attenuating CD8+ T cell infiltration
Z. Yi, J. Liu, H. Deng, H. Jiao, X. Zu
This study identifies RBBP8NL as a factor that reduces immune response in tumors by creating a non-inflammatory microenvironment and limiting CD8+ T cell infiltration, suggesting it as a target for improving immunotherapy.
bioRxiv · Jan 21, 2024 · PreprintCancer Biology